Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Markov microsimulation model

Authors

  • Diana Magee University of Toronto
  • Douglas Cheung Division of Urology, Department of Surgery, University Health Network, University of Toronto
  • Amanda Hird Division of Urology, Department of Surgery, University Health Network, University of Toronto
  • Srikala S. Sridhar Division of Medical Oncology, Department of Internal Medicine, University of Toronto
  • Charles Catton Department of Radiation Oncology, University of Toronto
  • Peter Chung Department of Radiation Oncology, University of Toronto
  • Alejandro Berlin Department of Radiation Oncology, University of Toronto
  • Padraig Warde Department of Radiation Oncology, University of Toronto
  • Alexandre Zlotta Division of Urology, Department of Surgery, University Health Network, University of Toronto
  • Neil Fleshner Division of Urology, Department of Surgery, University Health Network, University of Toronto
  • Girish S. Kulkarni Division of Urology, Department of Surgery, University Health Network, University of Toronto

DOI:

https://doi.org/10.5489/cuaj.7453

Keywords:

trimodal therapy; radical cystectomy; decision analysis; Markov model

Abstract

Introduction: Radical cystectomy (RC) is the historic gold standard treatment for muscle-invasive bladder cancer (MIBC), but trimodal therapy (TMT) has emerged as a valid therapeutic option for select patients. Given that prospective clinical trials have been difficult to perform in this area, our aim was to compare these two primary treatment strategies using decision analytic methods.

Methods: A two-dimensional Markov microsimulation model was constructed using TreeAge Pro to compare RC and TMT for patients with newly diagnosed MIBC. A comprehensive literature search was used to populate model probabilities and utilities. Our primary outcome was quality-adjusted life expectancy (QALE). Secondary outcomes included crude life expectancy (LE) and bladder cancer recurrences. The simulated patient for our model was an adult with MIBC (pT2-4 N0 M0) who was a candidate for either RC or TMT.

Results: A total of 500 000 patients were simulated. TMT resulted in an estimated mean QALE of 7.48 vs. 7.41 for RC. However, the average LE for patients treated with TMT was lower compared with RC (10.20 vs. 10.74 years). A sensitivity analysis evaluating the impact of age showed that younger patients treated with RC had greater QALE and longer LE than those treated with TMT; inverse findings were observed for elderly patients. Overall, 39.4% of patients treated with TMT experienced a bladder recurrence.

Conclusions: RC results in a longer LE compared to TMT (0.54 years), but with a lower QALE (-0.07 years). The preferred treatment strategy varied with patient age.

Downloads

Download data is not yet available.

Author Biography

Diana Magee, University of Toronto

Resident, Division of Urology, Department of Surgery 

University of Toronto

 

Downloads

Published

2021-11-18

How to Cite

Magee, D., Cheung, D., Hird, A., Sridhar, S. S., Catton, C., Chung, P., Berlin, A., Warde, P., Zlotta, A., Fleshner, N., & Kulkarni, G. S. (2021). Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Markov microsimulation model. Canadian Urological Association Journal, 16(4), E197–204. https://doi.org/10.5489/cuaj.7453

Issue

Vol. 16 No. 4 (2022): CUAJ April

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.